Roche Holding Valuation
| RHO6 Stock | EUR 31.48 1.23 4.07% |
At this time, the company appears to be fairly valued. Roche Holding holds a recent Real Value of €30.5 per share. The prevailing price of the company is €31.48. Our model determines the value of Roche Holding from analyzing the company fundamentals such as Shares Outstanding of 6.39 B, return on equity of 0.45, and Operating Margin of 0.32 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Roche Holding's price fluctuation is very steady at this time. Calculation of the real value of Roche Holding is based on 3 months time horizon. Increasing Roche Holding's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Roche stock is determined by what a typical buyer is willing to pay for full or partial control of Roche Holding Ltd. Since Roche Holding is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Roche Stock. However, Roche Holding's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 31.48 | Real 30.5 | Hype 31.48 | Naive 31.28 |
The real value of Roche Stock, also known as its intrinsic value, is the underlying worth of Roche Holding Company, which is reflected in its stock price. It is based on Roche Holding's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Roche Holding's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Roche Holding Ltd helps investors to forecast how Roche stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Roche Holding more accurately as focusing exclusively on Roche Holding's fundamentals will not take into account other important factors: Roche Holding Total Value Analysis
Roche Holding Ltd is at this time estimated to have takeover price of 273.87 B with market capitalization of 217.1 B, debt of 16.08 B, and cash on hands of 12.34 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Roche Holding fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
| 273.87 B | 217.1 B | 16.08 B | 12.34 B |
Roche Holding Investor Information
The company last dividend was issued on the 16th of March 2023. Roche Holding had 2:1 split on the 27th of February 2014. Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE HLDG operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 101465 people. To find out more about Roche Holding Ltd contact Severin Schwan at 41 61 688 11 11 or learn more at https://www.roche.com.Roche Holding Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Roche Holding has an asset utilization ratio of 68.03 percent. This implies that the Company is making €0.68 for each dollar of assets. An increasing asset utilization means that Roche Holding Ltd is more efficient with each dollar of assets it utilizes for everyday operations.Roche Holding Ownership Allocation
Roche Holding owns a total of 6.39 Billion outstanding shares. Roughly 99.0 pct. of Roche Holding outstanding shares are held by general public with 1.28 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Roche Holding Profitability Analysis
The company reported the revenue of 62.8 B. Net Income was 13.93 B with profit before overhead, payroll, taxes, and interest of 47.83 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Roche Holding's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Roche Holding and how it compares across the competition.
About Roche Holding Valuation
The stock valuation mechanism determines the current worth of Roche Holding Ltd on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Roche Holding Ltd. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Roche Holding based exclusively on its fundamental and basic technical indicators. By analyzing Roche Holding's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Roche Holding's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Roche Holding. We calculate exposure to Roche Holding's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Roche Holding's related companies.Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE HLDG operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 101465 people.
8 Steps to conduct Roche Holding's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Roche Holding's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Roche Holding's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Roche Holding's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Roche Holding's revenue streams: Identify Roche Holding's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Roche Holding's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Roche Holding's growth potential: Evaluate Roche Holding's management, business model, and growth potential.
- Determine Roche Holding's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Roche Holding's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Roche Stock analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |